Form 4: Vaxart SVP, Chief Scientific Officer Sean Tucker Reports Stock Transaction

Sean Tucker, SVP and Chief Scientific Officer of Vaxart, Inc., reports the withholding of shares to cover income tax obligations related to vested RSUs.

Summary

• On February 2, 2025, Sean Tucker, the SVP, Chief Scientific Officer of Vaxart, Inc. [VXRT], had shares withheld by the issuer to satisfy income tax obligations related to the vesting of Restricted Stock Units (RSUs).
• A total of 9,242 shares of common stock were withheld at a price of $0.6798 per share.
• Following the transaction, Tucker directly owns 346,453 shares of Vaxart common stock.
• Tucker also indirectly owns 51,465 shares through joint tenancy with Frances Chang and Sean Tucker, and 9,060 shares through his spouse.

Sentiment

Score: 5

Explanation: This is a neutral filing related to standard compensation practices. It doesn't indicate positive or negative sentiment.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates the vesting of RSUs and the subsequent withholding of shares to cover tax obligations, a common practice.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine tax-related withholding of shares.

Key Dates

Keywords

Form 4, Vaxart, Sean Tucker, VXRT, Stock Transaction, RSUs, Beneficial Ownership, SVP, Chief Scientific Officer